Terms: = Bone cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2
100 results:
1. An ATPase-Mimicking MXene nanozyme pharmacologically breaks the ironclad defense system for ferroptosis cancer therapy.
Wang H; Liu X; Yan X; Du Y; Pu F; Ren J; Qu X
Biomaterials; 2024 Jun; 307():122523. PubMed ID: 38432004
[TBL] [Abstract] [Full Text] [Related]
2. Curcumin induces ferroptosis and apoptosis in osteosarcoma cells by regulating nrf2/GPX4 signaling pathway.
Yuan C; Fan R; Zhu K; Wang Y; Xie W; Liang Y
Exp Biol Med (Maywood); 2023 Dec; 248(23):2183-2197. PubMed ID: 38166505
[TBL] [Abstract] [Full Text] [Related]
3. Down-Regulation of CYP3A4 by the K
Ohya S; Kajikuri J; Kito H; Matsui M
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958656
[TBL] [Abstract] [Full Text] [Related]
4. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs/AKT/nrf2 pathway and reducing PD-L1 expression to attenuate immune evasion.
Zhang Y; Shen G; Meng T; Lv Z; Li X; Li J; Li K
Int Immunopharmacol; 2023 Dec; 125(Pt B):111181. PubMed ID: 37951196
[TBL] [Abstract] [Full Text] [Related]
5. Glutamine metabolism controls amphiregulin-facilitated chemoresistance to cisplatin in human chondrosarcoma.
Wu YY; Law YY; Huang YW; Tran NB; Lin CY; Lai CY; Huang YL; Tsai CH; Ko CY; Chou MC; Huang WC; Cheng FJ; Fong YC; Tang CH
Int J Biol Sci; 2023; 19(16):5174-5186. PubMed ID: 37928274
[TBL] [Abstract] [Full Text] [Related]
6. Targeting the NF-E2-related factor 2 pathway for overcoming leukemia.
Harifi-Mood MS; Daroudi M; Darroudi M; Naseri K; Samarghandian S; Farkhondeh T
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127594. PubMed ID: 37890739
[TBL] [Abstract] [Full Text] [Related]
7. Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in nrf2-deficient mice.
Duarte TL; Lopes M; Oliveira M; Santos AG; Vasco C; Reis JP; Antunes AR; Gonçalves A; Chacim S; Oliveira C; Porto B; Teles MJ; Moreira AC; Silva AMN; Schwessinger R; Drakesmith H; Henrique R; Porto G; Duarte D
Leukemia; 2024 Jan; 38(1):96-108. PubMed ID: 37857886
[TBL] [Abstract] [Full Text] [Related]
8. Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Gerratana L; Davis AA; Velimirovic M; Clifton K; Hensing WL; Shah AN; Dai CS; Reduzzi C; D'Amico P; Wehbe F; Medford A; Wander SA; Gradishar WJ; Behdad A; Puglisi F; Ma CX; Bardia A; Cristofanilli M
Breast Cancer Res; 2023 Oct; 25(1):112. PubMed ID: 37784176
[TBL] [Abstract] [Full Text] [Related]
9. Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors.
Wang X; Su S; Zhu Y; Cheng X; Cheng C; Chen L; Lei A; Zhang L; Xu Y; Ye D; Zhang Y; Li W; Zhang J
Nat Commun; 2023 Sep; 14(1):5778. PubMed ID: 37723178
[TBL] [Abstract] [Full Text] [Related]
10. cancer-Erythrocyte Membrane-Mimicking Fe
Yu K; Chen Y; Zhang L; Zheng Y; Chen J; Wang Z; Yu X; Song K; Dong Y; Xiong F; Dong Z; Zhu H; Sheng G; Zhu M; Yuan X; Guan H; Xiong J; Liu Y; Li F
ACS Appl Mater Interfaces; 2023 Sep; 15(38):44689-44710. PubMed ID: 37699536
[TBL] [Abstract] [Full Text] [Related]
11. Paradox: Curcumin, a Natural Antioxidant, Suppresses Osteosarcoma Cells via Excessive Reactive Oxygen Species.
Xu C; Wang M; Zandieh Doulabi B; Sun Y; Liu Y
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569346
[TBL] [Abstract] [Full Text] [Related]
12. TAZ upregulates MIR-224 to inhibit oxidative stress response in multiple myeloma.
Abegunde SO; Grieve S; Reiman T
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1879. PubMed ID: 37539777
[TBL] [Abstract] [Full Text] [Related]
13. Targeted Silencing of nrf2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide.
Khodakarami A; Kashani MA; Nazer A; Kheshti AM; Rashidi B; Karpisheh V; Masjedi A; Abolhasani S; Izadi S; Bagherifar R; Hejazian SS; Mohammadi H; Movassaghpour A; Feizi AAH; Hojjat-Farsangi M; Jadidi-Niaragh F
Cell Commun Signal; 2023 Aug; 21(1):188. PubMed ID: 37528446
[TBL] [Abstract] [Full Text] [Related]
14. A risk score model based on endoplasmic reticulum stress related genes for predicting prognostic value of osteosarcoma.
Zhao Y; Gao J; Fan Y; Xu H; Wang Y; Yao P
BMC Musculoskelet Disord; 2023 Jun; 24(1):519. PubMed ID: 37353812
[TBL] [Abstract] [Full Text] [Related]
15. [Effects of fucoidan inducing impairment of human osteosarcoma cell 143B and its mechanism].
Wang QQ; Lin Q; Shan WY; Zhang T; Li YR; Zhang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):739-744. PubMed ID: 37308428
[No Abstract] [Full Text] [Related]
16. Baicalin induces ferroptosis in osteosarcomas through a novel nrf2/xCT/GPX4 regulatory axis.
Wen RJ; Dong X; Zhuang HW; Pang FX; Ding SC; Li N; Mai YX; Zhou ST; Wang JY; Zhang JF
Phytomedicine; 2023 Jul; 116():154881. PubMed ID: 37209607
[TBL] [Abstract] [Full Text] [Related]
17. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract] [Full Text] [Related]
18. Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma.
Boiarsky D; Lydon CA; Chambers ES; Sholl LM; Nishino M; Skoulidis F; Heymach JV; Luo J; Awad MA; Janne PA; Van Allen EM; Barbie DA; Vokes NI
Ann Oncol; 2023 Jul; 34(7):589-604. PubMed ID: 37121400
[TBL] [Abstract] [Full Text] [Related]
19. Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline.
Melrose J; Smith MM
Front Biosci (Elite Ed); 2022 Oct; 14(4):27. PubMed ID: 36575843
[TBL] [Abstract] [Full Text] [Related]
20. Comparison between Pelvic IMRT and 3D-CRT in Combination with Chemotherapy via nrf2 Expression on the High-Risk Endometrial cancer.
Wang N; Zhang X; Xu S; Li X; Meng Y; Dou Z
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(6):267-273. PubMed ID: 35818187
[TBL] [Abstract] [Full Text] [Related]
[Next]
